Physician

Rachel Reina, M.D.

According to 2025 Medicare claims, Rachel Reina, M.D. (NPI: 1780642330) practices micrographic dermatologic surgery in the Slidell-Mandeville-Covington, LA market, with the plurality of this provider's patient population coming from St. Tammany, LA. This provider's primary affiliated billing organization is BALDONE DERMATOLOGY, APMC (NPI: 1740235969; TIN: 721409108) and primary practice location at 70433-7512.

Reina's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 565 traditional Medicare patients, billed 4,497 HCPCS/CPT codes, and received $336,915 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 887 prescription claims across 332 beneficiaries totaling $194,284 in drug costs, led by Metronidazole (Metronidazole). Open Payments data shows 57 records totaling $1,222. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $55,395 and ending at $194,284. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$208K$416K2015 Medicare payment: $410,350 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $403,226 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $385,078 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $385,605 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $415,523 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $338,792 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $359,796 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $328,629 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $328,355 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $336,915 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156425,559$410,350
20165986,087$403,226
20176026,034$385,078
20186455,637$385,605
20196385,793$415,523
20205684,862$338,792
20215634,860$359,796
20225504,847$328,629
20235364,784$328,355
20245654,497$336,915

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$97K$194K2015 Drug cost: $55,395 (USD; Tot_Drug_Cst)2016 Drug cost: $43,826 (USD; Tot_Drug_Cst)2017 Drug cost: $44,473 (USD; Tot_Drug_Cst)2018 Drug cost: $69,354 (USD; Tot_Drug_Cst)2019 Drug cost: $45,926 (USD; Tot_Drug_Cst)2020 Drug cost: $66,314 (USD; Tot_Drug_Cst)2021 Drug cost: $64,920 (USD; Tot_Drug_Cst)2022 Drug cost: $31,610 (USD; Tot_Drug_Cst)2023 Drug cost: $30,521 (USD; Tot_Drug_Cst)2024 Drug cost: $194,284 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015227625$55,395
2016214568$43,826
2017256630$44,473
2018289657$69,354
2019292707$45,926
2020300770$66,314
2021337863$64,920
2022324842$31,610
2023337865$30,521
2024332887$194,284

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more161219$85
17110Destruction of skin growth, 1-14 growths172213$71
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more345505$57
17000Destruction of precancer skin growth, 1 growth289423$34
17003Destruction of precancer skin growth, 2-14 growths2311,626$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
MetronidazoleMetronidazole371,023$3,853
Betamethasone DipropionateBetamethasone Dipropionate391,199$2,232
FluocinonideFluocinonide461,464$1,639
Doxycycline MonohydrateDoxycycline Monohydrate582,505$1,438
Triamcinolone AcetonideTriamcinolone Acetonide862,532$1,020

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.57$1,222ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Rachel Reina, M.D.?

Tedicare shows public-source Medicare data for Rachel Reina, M.D. (NPI 1780642330), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rachel Reina, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Rachel Reina, M.D.?

Rachel Reina, M.D. is linked to BALDONE DERMATOLOGY, APMC (billing NPI 1740235969) in the available physician profile data.

Does Rachel Reina, M.D. have Open Payments data?

Rachel Reina, M.D. has 57 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.